Market Highlights: RXO Inc (RXO) Ends on a Low Note at 16.34

Ulysses Smith

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

The price of RXO Inc (NYSE: RXO) closed at $16.34 in the last session, down -1.51% from day before closing price of $16.59. In other words, the price has decreased by -$1.51 from its previous closing price. On the day, 1.4 million shares were traded. RXO stock price reached its highest trading level at $17.01 during the session, while it also had its lowest trading level at $16.34.

Ratios:

We take a closer look at RXO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 1.35. In the meantime, Its Debt-to-Equity ratio is 0.43 whereas as Long-Term Debt/Eq ratio is at 0.37.

On March 13, 2025, Truist started tracking the stock assigning a Buy rating and target price of $24.

On March 07, 2025, Deutsche Bank started tracking the stock assigning a Hold rating and target price of $19.Deutsche Bank initiated its Hold rating on March 07, 2025, with a $19 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 14 ’25 when Szlosek Thomas A bought 7,500 shares for $16.65 per share. The transaction valued at 124,875 led to the insider holds 16,200 shares of the business.

Szlosek Thomas A bought 8,700 shares of RXO for $125,354 on May 09 ’25. The Director now owns 8,700 shares after completing the transaction at $14.41 per share. On Nov 12 ’24, another insider, Nettles Michelle, who serves as the Director of the company, bought 1,800 shares for $27.89 each. As a result, the insider paid 50,202 and bolstered with 15,185 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXO now has a Market Capitalization of 2720548352 and an Enterprise Value of 3340551424. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.48 while its Price-to-Book (P/B) ratio in mrq is 1.69. Its current Enterprise Value per Revenue stands at 0.601 whereas that against EBITDA is 24.384.

Stock Price History:

The Beta on a monthly basis for RXO is 1.42, which has changed by -0.43983543 over the last 52 weeks, in comparison to a change of 0.1443547 over the same period for the S&P500. Over the past 52 weeks, RXO has reached a high of $31.98, while it has fallen to a 52-week low of $12.19. The 50-Day Moving Average of the stock is 1.93%, while the 200-Day Moving Average is calculated to be -8.09%.

Shares Statistics:

According to the various share statistics, RXO traded on average about 1.92M shares per day over the past 3-months and 1684130 shares per day over the past 10 days. A total of 163.97M shares are outstanding, with a floating share count of 160.58M. Insiders hold about 2.08% of the company’s shares, while institutions hold 105.81% stake in the company. Shares short for RXO as of 1759190400 were 11717796 with a Short Ratio of 6.09, compared to 1756425600 on 7917682. Therefore, it implies a Short% of Shares Outstanding of 11717796 and a Short% of Float of 19.99.

Earnings Estimates

The firm’s stock currently is rated by 20.0 analysts. The consensus estimate for the next quarter is $0.07, with high estimates of $0.09 and low estimates of $0.05.

Analysts are recommending an EPS of between $0.15 and $0.07 for the fiscal current year, implying an average EPS of $0.12. EPS for the following year is $0.37, with 20.0 analysts recommending between $0.67 and $0.21.

Revenue Estimates

According to 17 analysts,. The current quarter’s revenue is expected to be $1.43B. It ranges from a high estimate of $1.49B to a low estimate of $1.39B. As of. The current estimate, RXO Inc’s year-ago sales were $1.04BFor the next quarter, 17 analysts are estimating revenue of $1.56B. There is a high estimate of $1.66B for the next quarter, whereas the lowest estimate is $1.41B.

A total of 19 analysts have provided revenue estimates for RXO’s current fiscal year. The highest revenue estimate was $6.06B, while the lowest revenue estimate was $5.66B, resulting in an average revenue estimate of $5.86B. In the same quarter a year ago, actual revenue was $4.55BBased on 19 analysts’ estimates, the company’s revenue will be $6.21B in the next fiscal year. The high estimate is $6.62B and the low estimate is $5.74B.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.